Short-course Adjuvant Trastuzumab Will Increase Cure Rates in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde（2017）
关键词
Trastuzumab,breast cancer,cure rates
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要